Cigna

FTC Sues Big Three PBMs for Artificially Inflating Insulin Prices Through Rebate Schemes

| Importance: 9/10

The Federal Trade Commission filed an administrative antitrust complaint against the three largest pharmacy benefit managers—CVS Caremark, Express Scripts (Cigna), and OptumRx (UnitedHealth)—and their affiliated group purchasing organizations, charging them with anticompetitive and unfair practices …

Federal Trade Commission Lina Khan CVS Caremark Express Scripts OptumRx +3 more healthcare pbm pharmacy antitrust ftc +3 more
Read more →

ProPublica Exposes Cigna's Automated PXDX System Denying 300,000 Claims in Two Months at 1.2 Seconds Per Case

| Importance: 9/10

On March 13, 2023, ProPublica published an investigation revealing that health insurance giant Cigna used an automated system called PXDX to deny 300,000 claims over two months without doctors examining individual patient files—spending an average of just 1.2 seconds reviewing each case before …

Cigna ProPublica House Committee on Energy and Commerce healthcare insurance-fraud systematic-corruption investigative-journalism
Read more →

Cigna-Express Scripts $52 Billion Merger Approved: DOJ Greenlights PBM Oligopoly

| Importance: 9/10

The Department of Justice approved Cigna’s $52 billion acquisition of Express Scripts, one of the three largest pharmacy benefit managers, completing the deal announced in March 2018. Assistant Attorney General Makan Delrahim stated that after a six-month investigation reviewing over two …

Cigna Express Scripts Department of Justice Makan Delrahim David Cordani healthcare pbm pharmacy antitrust regulatory-capture +2 more
Read more →